Antimicrobial therapy in palliative care: an overview
- 206 Downloads
In the advanced stages of illness, patients often face challenging decisions regarding their treatment and overall medical care. Terminal ill patients are commonly affected by infections. However, in palliative care, the use of antimicrobials can be an ethical dilemma. Deciding whether to treat, withhold, or withdraw the antimicrobial treatment for an infection can be difficult. Antimicrobial administration can lead to adverse outcomes but the two main benefits, longer survival and symptom relief, are the main reasons why physicians prescribe antimicrobial when treating terminally ill patients. For the patient who has an irreversible advanced heart or lung disease, or an advanced dementia, or a metastatic cancer, it is easier the decision of withholding mechanical ventilation, tube feeding, and dialysis than antibiotherapy. To characterize infections, agents, and their treatments in palliative care, we conducted a review of the literature. We also included some tips to help health professionals to guide their clinical approach.
KeywordsPalliative care End of life Antimicrobians Antibiotics Infections Survival
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflicts of interest.
- 1.World Health Organization (2002). National cancer control programmes: policies and managerial guidelines. http://apps.who.int/iris/bitstream/10665/42494/1/9241545577.pdf. Accessed 13 April 2016
- 2.DeVita V, Hellman S, Rosenberg S (2001). Cancer principles and practice of oncology, Sixth edition. Lippincott, Williams.Google Scholar
- 11.Lagman R, Panta R, Walsh D (1996) Infectious complications in advanced cancer. Support Care Cancer 4:226Google Scholar
- 13.Glauser M, Zinner S (1982) Mechanisms of acquisition and development of bacterial infections in cancer patients. Raven Press, New York, pp 13–24Google Scholar
- 28.Kuehn N, MacEachern T, Miller M, Spachynski K (1992) Nosocomial infections (NI) on a palliative care unit (PCU): a prospective comparison study. In: Poster for 9th international congress on Care of the Terminally ill. Canada, MontrealGoogle Scholar
- 39.Yoshikawa TT, Norman DC (1987) Diagnostic approach to infections. Igaku-Shoin, New York, pp 26–31Google Scholar
- 43.Green K, Webster H, Watanabe S, Fainsinger R (1994) Management of nosocomial respiratory tract infections in terminally ill cancer patients. J Palliative Care 10(4):31–34Google Scholar
- 47.Miller D (1994) Withholding antibiotics as a form of care: an ethical perspective. Springer, New York, pp 283–298Google Scholar